Core A The Administrative Core will provide administrative and logistic support and budgetary oversight for the different scientific projects. (1) The Core will manage and oversee the scientific efforts of the Projects. To this end the Core will organize regular meetings of the investigators, their collaborators and subcontractors. In addition the Core will arrange for meetings of the Executive Committee and the annual meeting of the External Scientific Advisory Board. (2) The Core will produce and submit the annual progress report to DAIDS. (3) The Core will establish and maintain a secure database for data collection and storage. This database will facilitate not only annual reports and interactions between the projects but may also be used for data sharing. (4) The Core will provide statistical support to all of the pre-clinical research efforts of the different projects. This will include support in experimental designs and data analyses. (4) The Core will provide budgetary oversight over the program. (5) The Core will obtain and maintain 'umbrella'IACUC and IRB approvals to cover the scientific efforts of the program. (6) The Core will arrange for the resolution of potential conflicts;depending on the type of conflict this may further involve DAIDS and members of the External Scientific Advisory Board. (7) In case the PI of this program becomes unable to fulfill her obligations to this program, the Core will arrange for meeting of the Executive Committee with representatives from DAIDS and the External Scientific Advisory Board to find a new PI in a timely manner. (8) The Core will facilitate sharing of reagents by assisting in speedy execution of material transfer agreements.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI074078-03
Application #
7925782
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
3
Fiscal Year
2009
Total Cost
$246,655
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Emmer, Kristel L; Wieczorek, Lindsay; Tuyishime, Steven et al. (2016) Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140. AIDS 30:2405-2414
Small, Juliana C; Haut, Larissa H; Bian, Ang et al. (2014) The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses. J Leukoc Biol 96:821-31
Tuyishime, Steven; Haut, Larissa H; Zhu, Caihong et al. (2014) Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid. Vaccine 32:3386-92
Cervasi, Barbara; Carnathan, Diane G; Sheehan, Katherine M et al. (2013) Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac. J Virol 87:9420-30
Lasaro, Marcio O; Sazanovich, Marina; Giles-Davis, Wynetta et al. (2011) Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice. Mol Ther 19:1727-36
Small, Juliana C; Ertl, Hildegund C J (2011) Viruses - from pathogens to vaccine carriers. Curr Opin Virol 1:241-5
Makedonas, George; Hutnick, Natalie; Haney, Danielle et al. (2010) Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 6:e1000798
Haut, Larissa H; Lin, Shih W; Tatsis, Nia et al. (2010) Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag. Eur J Immunol 40:3426-38
Hutnick, Natalie A; Carnathan, Diane; Demers, Korey et al. (2010) Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine 28:1932-41
Chen, H; Xiang, Z Q; Li, Y et al. (2010) Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol 84:10522-32

Showing the most recent 10 out of 18 publications